Acrivon Therapeutics Inc. (ACRV) NASDAQ
$8.56 - (-)
Market Cap: $264.31M
As of 05/16/24 12:00 AM EDT. Market open.
Acrivon Therapeutics Inc. (ACRV)
NASDAQ
$8.56
- (-)
Market Cap: $264.31M
As of 05/16/24 12:00 AM EDT. Market open.
Add to Portfolio
acrivon therapeutics is a biotech company specializing in drug development through early clinical treatment success using our unique predictive biomarker approach. our technology platform is based on integrating drug-regulated, global proteomics with focused intact tissue digital imaging to develop drug-tailored biomarker signatures for prospective patient responder identification. the ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
42
URL
Address
.
PRICE CHART FOR ACRIVON THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$8.56
Days Range
$8.45 - $8.76
52 week range
$3.19 - $14.03
Volume
2,582
Avg. Volume (30 days)
244,137
Market Cap
$264.31M
Dividend Yield
-
P/E
-
Shares Outstanding
30,876,932
Open
-
Previous Close
$8.56
Days Range
$8.45 - $8.76
52 week range
$3.19 - $14.03
Volume
2,582
Avg. Volume (30 days)
244,137
Market Cap
$264.31M
Dividend Yield
-
P/E
-
Shares Outstanding
30,876,932
FINANCIAL STATEMENTS FOR ACRIVON THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ACRIVON THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Peterson Katharine | Chief Accounting Officer | May 14, 2024 | Option Exercise | $8.36 | 99 | 828 | 4,733 | May 16, 2024, 07:05 PM |
| Miller Mary | Chief Legal Officer | May 14, 2024 | Option Exercise | $8.36 | 184 | 1,538 | 39,709 | May 16, 2024, 07:03 PM |
| Masson Kristina | EVP - Business Operations | May 14, 2024 | Option Exercise | $8.36 | 490 | 4,096 | 317,736 | May 16, 2024, 07:02 PM |
| Holm-Jorgensen Rasmus | Chief Financial Officer | May 14, 2024 | Option Exercise | $8.36 | 368 | 3,076 | 27,258 | May 16, 2024, 07:00 PM |
| Gamelin Erick | Chief Development Officer | May 14, 2024 | Option Exercise | $8.36 | 402 | 3,361 | 17,765 | May 16, 2024, 06:58 PM |
| Devroe Eric | Chief Operating Officer | May 14, 2024 | Option Exercise | $8.36 | 613 | 5,125 | 59,097 | May 16, 2024, 06:56 PM |
| Blume-Jensen Peter | President and CEO | May 14, 2024 | Option Exercise | $8.36 | 54,918 | 459,114 | 2,561,894 | May 16, 2024, 06:54 PM |
| Miller Mary | Chief Legal Officer | Apr 17, 2024 | Option Exercise | $10.34 | 558 | 5,770 | 39,893 | Apr 19, 2024, 04:10 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Apr 11, 2024 | Option Exercise | $8.50 | 3,530,000 | 30,005,000 | 7,914,206 | Apr 15, 2024, 04:15 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Apr 11, 2024 | Buy | $8.50 | 2,353,000 | 20,000,500 | 5,360,858 | Apr 15, 2024, 08:53 AM |
| Miller Mary | Chief Legal Officer | Feb 14, 2024 | Option Exercise | $3.40 | 217 | 738 | 40,451 | Feb 16, 2024, 05:14 PM |
| Masson Kristina | EVP - Business Operations | Feb 14, 2024 | Option Exercise | $3.40 | 579 | 1,969 | 318,226 | Feb 16, 2024, 05:13 PM |
| Holm-Jorgensen Rasmus | Chief Financial Officer | Feb 14, 2024 | Option Exercise | $3.40 | 434 | 1,476 | 27,626 | Feb 16, 2024, 05:12 PM |
| Gamelin Erick | Chief Development Officer | Feb 14, 2024 | Option Exercise | $3.40 | 468 | 1,591 | 18,167 | Feb 16, 2024, 05:10 PM |
| Devroe Eric | Chief Operating Officer | Feb 14, 2024 | Option Exercise | $3.40 | 723 | 2,458 | 59,710 | Feb 16, 2024, 05:08 PM |
| Blume-Jensen Peter | President and CEO | Feb 14, 2024 | Option Exercise | $3.40 | 41,861 | 142,327 | 2,616,812 | Feb 16, 2024, 05:06 PM |
| Miller Mary | Chief Legal Officer | Jan 17, 2024 | Option Exercise | $4.35 | 652 | 2,836 | 40,668 | Jan 19, 2024, 04:24 PM |
| Miller Mary | Chief Legal Officer | Nov 14, 2023 | Option Exercise | $5.08 | 735 | 3,734 | 41,320 | Nov 16, 2023, 07:43 PM |
| Masson Kristina | EVP - Business Operations | Nov 14, 2023 | Option Exercise | $5.08 | 1,900 | 9,652 | 318,805 | Nov 16, 2023, 07:42 PM |
| Holm-Jorgensen Rasmus | Chief Financial Officer | Nov 14, 2023 | Option Exercise | $5.08 | 1,470 | 7,468 | 28,060 | Nov 16, 2023, 07:42 PM |
| Gamelin Erick | Chief Medical Officer | Nov 14, 2023 | Option Exercise | $5.08 | 1,395 | 7,087 | 18,635 | Nov 16, 2023, 07:41 PM |
| Devroe Eric | Chief Operating Officer | Nov 14, 2023 | Option Exercise | $5.08 | 2,450 | 12,446 | 60,433 | Nov 16, 2023, 07:41 PM |
| Blume-Jensen Peter | President and CEO | Nov 14, 2023 | Option Exercise | $5.08 | 239,023 | 1,214,237 | 2,658,673 | Nov 16, 2023, 07:41 PM |
| Miller Mary | Chief Legal Officer | Oct 17, 2023 | Option Exercise | $5.48 | 2,232 | 12,231 | 42,055 | Oct 19, 2023, 07:45 PM |
| Chione Ltd | 10% Owner | Jun 26, 2023 | Sale | $12.93 | 16 | 207 | 3,848,632 | Jun 28, 2023, 03:47 PM |
| Holm-Jorgensen Rasmus | Chief Financial Officer | Jun 16, 2023 | Option Exercise | $3.63 | 9,500 | 34,485 | 29,530 | Jun 20, 2023, 05:21 PM |
| Chione Ltd | 10% Owner | Jun 15, 2023 | Sale | $12.14 | 2,056 | 24,960 | 3,848,648 | Jun 20, 2023, 05:15 PM |
| Chione Ltd | 10% Owner | Jun 14, 2023 | Sale | $12.13 | 893 | 10,832 | 3,850,704 | Jun 14, 2023, 06:33 PM |
| Chione Ltd | 10% Owner | Jun 13, 2023 | Sale | $12.30 | 3,000 | 36,900 | 3,851,597 | Jun 14, 2023, 06:33 PM |
| Chione Ltd | 10% Owner | Jun 12, 2023 | Sale | $12.34 | 2,000 | 24,680 | 3,854,597 | Jun 14, 2023, 06:33 PM |
| Devroe Eric | Chief Operating Officer | Jun 05, 2023 | Option Exercise | $1.04 | 9,225 | 9,594 | 62,883 | Jun 06, 2023, 04:15 PM |
| Blume-Jensen Peter | President and CEO | May 31, 2023 | Option Exercise | $3.88 | 33,605 | 130,387 | 2,403,702 | Jun 01, 2023, 08:40 PM |
| Chione Ltd | 10% Owner | Nov 17, 2022 | Buy | $12.50 | 400,000 | 5,000,000 | 3,856,597 | Nov 21, 2022, 06:26 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Nov 17, 2022 | Buy | $12.50 | 3,389,500 | 42,368,750 | 4,384,206 | Nov 21, 2022, 04:31 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Peterson Katharine | Chief Accounting Officer | 05/14/2024 | 828 |
| Miller Mary | Chief Legal Officer | 05/14/2024 | 1,538 |
| Masson Kristina | EVP - Business Operations | 05/14/2024 | 4,096 |
| Holm-Jorgensen Rasmus | Chief Financial Officer | 05/14/2024 | 3,076 |
| Gamelin Erick | Chief Development Officer | 05/14/2024 | 3,361 |
| Devroe Eric | Chief Operating Officer | 05/14/2024 | 5,125 |
| Blume-Jensen Peter | President and CEO | 05/14/2024 | 459,114 |
| Miller Mary | Chief Legal Officer | 04/17/2024 | 5,770 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 04/11/2024 | 30,005,000 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 04/11/2024 | 20,000,500 |
| Miller Mary | Chief Legal Officer | 02/14/2024 | 738 |
| Masson Kristina | EVP - Business Operations | 02/14/2024 | 1,969 |
| Holm-Jorgensen Rasmus | Chief Financial Officer | 02/14/2024 | 1,476 |
| Gamelin Erick | Chief Development Officer | 02/14/2024 | 1,591 |
| Devroe Eric | Chief Operating Officer | 02/14/2024 | 2,458 |
| Blume-Jensen Peter | President and CEO | 02/14/2024 | 142,327 |
| Miller Mary | Chief Legal Officer | 01/17/2024 | 2,836 |
| Miller Mary | Chief Legal Officer | 11/14/2023 | 3,734 |
| Masson Kristina | EVP - Business Operations | 11/14/2023 | 9,652 |
| Holm-Jorgensen Rasmus | Chief Financial Officer | 11/14/2023 | 7,468 |
| Gamelin Erick | Chief Medical Officer | 11/14/2023 | 7,087 |
| Devroe Eric | Chief Operating Officer | 11/14/2023 | 12,446 |
| Blume-Jensen Peter | President and CEO | 11/14/2023 | 1,214,237 |
| Miller Mary | Chief Legal Officer | 10/17/2023 | 12,231 |
| Chione Ltd | 10% Owner | 06/26/2023 | 207 |
| Holm-Jorgensen Rasmus | Chief Financial Officer | 06/16/2023 | 34,485 |
| Chione Ltd | 10% Owner | 06/15/2023 | 24,960 |
| Chione Ltd | 10% Owner | 06/14/2023 | 10,832 |
| Chione Ltd | 10% Owner | 06/13/2023 | 36,900 |
| Chione Ltd | 10% Owner | 06/12/2023 | 24,680 |
| Devroe Eric | Chief Operating Officer | 06/05/2023 | 9,594 |
| Blume-Jensen Peter | President and CEO | 05/31/2023 | 130,387 |
| Chione Ltd | 10% Owner | 11/17/2022 | 5,000,000 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 11/17/2022 | 42,368,750 |
Load More Insider Transactions
FUNDS WITH A POSITION IN ACRIVON THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 8,359,102 | 0.99% | 73.77% | Other |
| BLACKROCK INC. | 743,901 | 0.00012% | 31.47% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 242,846 | 0.00016% | 28.35% | Other |
| OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 126,949 | 0.06% | 35.86% | Value |
| RENAISSANCE TECHNOLOGIES LLC | 102,600 | 0.00115% | New | Other |
| BAKER BROS. ADVISORS LP | 52,885 | 0.00474% | New | Other |
| D. E. SHAW & CO., INC. | 31,939 | 0.00014% | Exited | Other |
CHANGE IN SHARES OUTSTANDING FOR ACRIVON THERAPEUTICS INC
STOCK BUYBACKS FOR ACRIVON THERAPEUTICS INC
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
1.16%
1Q
06/30/2023
1.67%
2Q
03/31/2023
1.91%
3Q
BUYBACK ANNOUNCEMENT(S) FOR ACRIVON THERAPEUTICS INC
LOADING...